"Tetrabenazine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug formerly used as an antipsychotic and treatment of various movement disorders. Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.
| Descriptor ID |
D013747
|
| MeSH Number(s) |
D03.633.100.834.850
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tetrabenazine".
Below are MeSH descriptors whose meaning is more specific than "Tetrabenazine".
This graph shows the total number of publications written about "Tetrabenazine" by people in this website by year, and whether "Tetrabenazine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 5 | 1 | 6 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Tetrabenazine" by people in Profiles.
-
Crushing of deutetrabenazine tablets limited to individual case. Am J Health Syst Pharm. 2021 08 30; 78(17):1552-1553.
-
On crushing of deutetrabenazine tablets. Am J Health Syst Pharm. 2021 08 30; 78(17):1551-1552.
-
Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia. J Comp Eff Res. 2019 10; 8(13):1077-1088.
-
Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study. J Clin Psychiatry. 2018 12 18; 80(1).
-
The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder. J Affect Disord. 2019 03 01; 246:217-223.
-
Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2018; 12:1215-1238.
-
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study. J Clin Psychiatry. 2017 Nov/Dec; 78(9):1344-1350.
-
Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review. J Comp Eff Res. 2018 02; 7(2):135-148.
-
Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment. J Clin Psychiatry. 2017 Sep/Oct; 78(8):1136-1147.
-
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder. Psychopharmacol Bull. 2017 08 01; 47(3):53-60.